Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.88
0.010.53%
At close: Dec 16, 4:00 PM EST
$1.88
N/A
After Hours: 5:40 PM EST
Comments
Loading...
BioXcel Therapeutics (BTAI) Stock Price, Quote, News & History
BTAINASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioXcel Therapeutics (BTAI) stock?
You can purchase shares of BioXcel Therapeutics (NASDAQ:BTAI) through any online brokerage.
Who are BioXcel Therapeutics (BTAI) competitors?
Other companies in BioXcel Therapeutics’s space includes: Kezar Life Sciences Inc (NASDAQ:KZR), Skye Bioscience Inc (NASDAQ:SKYE), Evaxion AS (NASDAQ:EVAX), FibroGen Inc (NASDAQ:FGEN) and Palatin Technologies Inc (AMEX:PTN).
What is the forecast, or price target, for BioXcel Therapeutics (BTAI) stock?
BioXcel Therapeutics has a consensus price target of $19.69.
What is the current price for BioXcel Therapeutics (BTAI)?
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $1.88 last updated December 16, 2025 at 5:40 PM EST.
Does BioXcel Therapeutics (BTAI) pay a dividend?
There are no upcoming dividends for BioXcel Therapeutics.
When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?
BioXcel Therapeutics does not have any upcoming earnings scheduled.
Is BioXcel Therapeutics (BTAI) going to split?
There is no upcoming split for BioXcel Therapeutics.
What sector and industry does BioXcel Therapeutics (BTAI) operate in?
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
